Literature DB >> 11807185

Subacute sclerosing panencephalitis.

R K Garg1.   

Abstract

Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder of childhood and early adolescence. It is caused by persistent defective measles virus. Brain biopsies or postmortem histopathological examination show evidence of astrogliosis, neuronal loss, degeneration of dendrites, demyelination, neurofibrillary tangles, and infiltration of inflammatory cells. Patients usually have behavioral changes, myoclonus, dementia, visual disturbances, and pyramidal and extrapyramidal signs. The disease has a gradual progressive course leading to death within 1-3 years. The diagnosis is based upon characteristic clinical manifestations, the presence of characteristic periodic EEG discharges, and demonstration of raised antibody titre against measles in the plasma and cerebrospinal fluid. Treatment for SSPE is still undetermined. A combination of oral isoprinosine (Inosiplex) and intraventricular interferon alfa appears to be the best effective treatment. Patients responding to treatment need to receive it life long. Effective immunisation against measles is the only solution presently available to the problem of this dreaded disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807185      PMCID: PMC1742261          DOI: 10.1136/pmj.78.916.63

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  82 in total

1.  The epidemiology of subacute sclerosing panencephalitis in England and Wales 1970-1989.

Authors:  C Miller; C P Farrington; K Harbert
Journal:  Int J Epidemiol       Date:  1992-10       Impact factor: 7.196

2.  Intravenous gamma-globulin treatment in a patient with subacute sclerosing panencephalitis.

Authors:  Y K Gürer; S Kükner; B Sarica
Journal:  Pediatr Neurol       Date:  1996-01       Impact factor: 3.372

3.  MRI findings in subacute sclerosing panencephalitis.

Authors:  B Anlar; I Saatçi; G Köse; K Yalaz
Journal:  Neurology       Date:  1996-11       Impact factor: 9.910

4.  Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence.

Authors:  T Cathomen; H Y Naim; R Cattaneo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Ophthalmoscopic findings in subacute sclerosing panencephalitis.

Authors:  S H Green; J D Wirtschafter
Journal:  Br J Ophthalmol       Date:  1973-10       Impact factor: 4.638

Review 6.  Clinical spectrum of measles.

Authors:  M Katz
Journal:  Curr Top Microbiol Immunol       Date:  1995       Impact factor: 4.291

7.  Different virus antibodies in serum and cerebrospinal fluid of patients suffering from subacute sclerosing panencephalitis.

Authors:  A M Abdelnoor; S S Dhib-Jalbut; F S Haddad
Journal:  J Neuroimmunol       Date:  1982-01       Impact factor: 3.478

8.  Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis.

Authors:  A A Salmi; E Norrby; M Panelius
Journal:  Infect Immun       Date:  1972-09       Impact factor: 3.441

9.  Cimetidine as an immunomodulator in subacute sclerosing panencephalitis: a double blind, placebo-controlled study.

Authors:  B Anlar; K Gücüyener; T Imir; K Yalaz; Y Renda
Journal:  Pediatr Infect Dis J       Date:  1993-07       Impact factor: 2.129

10.  Isoprinosine treatment in 18 patients with subacute sclerosing panencephalitis: a controlled study.

Authors:  F S Haddad; W S Risk
Journal:  Ann Neurol       Date:  1980-02       Impact factor: 10.422

View more
  57 in total

1.  Subacute sclerosing panencephalitis findings at MR imaging, diffusion MR imaging, and proton MR spectroscopy.

Authors:  R Nuri Sener
Journal:  AJNR Am J Neuroradiol       Date:  2004-05       Impact factor: 3.825

2.  Subacute sclerosing panencephalitis in a toddler.

Authors:  Mahesh Kamate; Ashwin Y Belludi; S N Madhusudana
Journal:  Indian J Pediatr       Date:  2011-12-15       Impact factor: 1.967

Review 3.  Juvenile parkinsonism: epidemiology, diagnosis and treatment.

Authors:  Teri R Thomsen; Robert L Rodnitzky
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

4.  Assessment of white matter damage in subacute sclerosing panencephalitis using quantitative diffusion tensor MR imaging.

Authors:  R Trivedi; R K Gupta; A Agarawal; K M Hasan; A Gupta; K N Prasad; G Bayu; D Rathore; R K S Rathore; P A Narayana
Journal:  AJNR Am J Neuroradiol       Date:  2006-09       Impact factor: 3.825

5.  Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy.

Authors:  Juliene K G Co; Saguna Verma; Ulziijargal Gurjav; Laarni Sumibcay; Vivek R Nerurkar
Journal:  J Infect Dis       Date:  2007-07-20       Impact factor: 5.226

6.  18F-FDG PET in a 10-year-old female patient with subacute sclerosing panencephalitis.

Authors:  Antonia Dimitrakopoulou-Strauss; Marion Wilmsmeyer; Stephan König; Susanne Schubert; K Wolfgang Neff; Uwe Haberkorn; Ludwig G Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-30       Impact factor: 9.236

7.  Correlation of quantitative diffusion tensor tractography with clinical grades of subacute sclerosing panencephalitis.

Authors:  R Trivedi; H Anuradha; A Agarwal; R K S Rathore; K N Prasad; R P Tripathi; R K Gupta
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-17       Impact factor: 3.825

8.  Optic neuritis and rapidly progressive necrotizing retinitis as the initial signs of subacute sclerosing panencephalitis: a case report with clinical and histopathologic findings.

Authors:  Merih Oray; Samuray Tuncer; Nur Kir; Murat Karacorlu; Ilknur Tugal-Tutkun
Journal:  Int Ophthalmol       Date:  2014-02-13       Impact factor: 2.031

9.  Acute bilateral vision loss as the presenting feature of subacute sclerosing panencephalitis.

Authors:  Suvasini Sharma; Bhuvan Chanana; Sheffali Gulati; Pradeep Venkatesh; Sarman Singh
Journal:  Indian J Pediatr       Date:  2009-11-04       Impact factor: 1.967

10.  Subacute sclerosing panencephalitis presenting as neuromyelitis optica.

Authors:  Tushar Premraj Raut; Maneesh Kumar Singh; Ravindra Kumar Garg; Pravin Umakant Naphade
Journal:  BMJ Case Rep       Date:  2012-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.